Nordea Investment Management Ab Neogenomics Inc Transaction History
Nordea Investment Management Ab
- $103 Billion
- Q2 2025
A detailed history of Nordea Investment Management Ab transactions in Neogenomics Inc stock. As of the latest transaction made, Nordea Investment Management Ab holds 81,960 shares of NEO stock, worth $475,368. This represents 0.0% of its overall portfolio holdings.
Number of Shares
81,960
Previous 81,960
-0.0%
Holding current value
$475,368
Previous $777,000
22.91%
% of portfolio
0.0%
Previous 0.0%
Shares
25 transactions
Others Institutions Holding NEO
# of Institutions
286Shares Held
126MCall Options Held
942KPut Options Held
172K-
Black Rock Inc. New York, NY19.7MShares$114 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.3MShares$82.7 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny6.72MShares$39 Million0.04% of portfolio
-
First Light Asset Management, LLC Edina, MN6.04MShares$35 Million7.36% of portfolio
-
Janus Henderson Group PLC London, X05.74MShares$33.3 Million0.03% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $730M
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...